Clinical Trial

The Implementation of Genetic Risk for Colorectal Cancer Screening

Study acronym: PRO-GENE-COLON
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The goal of this study is to investigate genetic risk for colorectal cancer utilizing polygenic risk scores (PRS) for adults over 45 who have not received their first colonoscopy. The main questions it hopes to address are: 1. How does knowledge of a patient's genetic risk for colorectal cancer affect the uptake of initial screening colonoscopies? 2. How do colonoscopy outcomes compare between genetic risk groups?
Trial Details
NCT Number NCT07621757
Lead Sponsor Endeavor Health
Conditions Colorectal Cancer, Colorectal Adenoma, Colorectal Polyp
Enrollment 100 participants
Start Date 2026-06-01
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-02